SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Aurobindo Pharma shares react after USFDA issues observation

USFDA issued one observation after inspecting an API manufacturing facility of Aurobindo Pharma’s wholly owned subsidiary Apitoria Pharma in Gaddapotharam, Telangana. The inspection ran Sept. 7–Sept. 15, and TradingView News says shares will remain in focus on Sept. 16.

AUROPHARMA

Aurobindo Pharma shares will remain in focus on September 16 after the USFDA issued one observation following an inspection of an API manufacturing facility of its wholly owned subsidiary Apitoria Pharma in Gaddapotharam, Telangana.The inspection was conducted from September 7 to September 15 and c…

Related stories